Assess imatinib TKI response using ELN 2020 milestones: BCR-ABL1 IS below 10% at 3 months, below 1% at 6 months, and below 0.1% (MMR) at 12 months as optimal response benchmarks.
Use the full interactive calculator below, or
CML Sokal Score
Medical Long-tail
CML Euro Score